• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可能为良性病变的定期乳房X线摄影随访:3184例连续病例的结果

Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases.

作者信息

Sickles E A

机构信息

Department of Radiology, University of California School of Medicine, San Francisco 94143-0628.

出版信息

Radiology. 1991 May;179(2):463-8. doi: 10.1148/radiology.179.2.2014293.

DOI:10.1148/radiology.179.2.2014293
PMID:2014293
Abstract

The author prospectively evaluated the value of periodic mammographic surveillance among 3,184 consecutive cases of nonpalpable, probably benign breast lesions detected with mammography. Follow-up consisted of four mammographic examinations during a 3- or 3.5-year period. Clinical outcome was ascertained in each case after the study period, whether or not patients complied with the protocol. Probably benign lesions were subsequently found to be malignant in 17 cases (positive predictive value for cancer, 0.5%). Fifteen of the 17 cancers were identified by means of interval mammographic change prior to development of a palpable mass; all 17 were stage 0 or stage 1 tumors. All 17 women who had cancer currently show no evidence of tumor recurrence (median duration of follow-up, 5 years). These results should help establish the validity of managing mammographically detected, probably benign lesions with periodic mammographic surveillance. By decreasing the number of biopsies of benign lesions and thereby substantially reducing costs, this approach may help overcome a major barrier to widespread use of mammographic screening.

摘要

作者前瞻性评估了在3184例经乳腺X线摄影检出的不可触及的、可能为良性的乳腺病变连续病例中进行定期乳腺X线摄影监测的价值。随访包括在3年或3.5年期间进行4次乳腺X线检查。在研究期结束后,无论患者是否遵守方案,均确定每例患者的临床结局。随后发现17例可能为良性的病变为恶性(癌症的阳性预测值为0.5%)。17例癌症中有15例是在可触及肿块出现之前通过乳腺X线检查的间期变化发现的;所有17例均为0期或1期肿瘤。目前所有17例患癌女性均无肿瘤复发迹象(中位随访时间为5年)。这些结果应有助于确立对经乳腺X线摄影检出的、可能为良性的病变进行定期乳腺X线摄影监测管理的有效性。通过减少良性病变的活检数量,从而大幅降低成本,这种方法可能有助于克服广泛应用乳腺X线筛查的一个主要障碍。

相似文献

1
Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases.可能为良性病变的定期乳房X线摄影随访:3184例连续病例的结果
Radiology. 1991 May;179(2):463-8. doi: 10.1148/radiology.179.2.2014293.
2
Nonpalpable, probably benign lesions: role of follow-up mammography.不可触及的、可能为良性的病变:随访乳腺钼靶摄影的作用
Radiology. 1992 Aug;184(2):409-14. doi: 10.1148/radiology.184.2.1620838.
3
Short-term follow-up results in 795 nonpalpable probably benign lesions detected at screening mammography.对在乳腺钼靶筛查中发现的795例不可触及的可能为良性病变进行的短期随访结果。
Radiology. 2001 May;219(2):475-83. doi: 10.1148/radiology.219.2.r01ma11475.
4
Ultrasonography as adjunct to mammography in the evaluation of breast tumors.超声检查作为乳腺钼靶检查的辅助手段用于乳腺肿瘤的评估。
Acta Radiol Suppl. 1999;420:1-47.
5
[Radiology of nonpalpable breast lesions].[不可触及乳腺病变的放射学]
Rev Med Univ Navarra. 1995 Oct-Dec;39(4):11-7.
6
Ability of mammography to reveal nonpalpable breast cancer in women with palpable breast masses.乳腺钼靶摄影术在有可触及乳腺肿块的女性中发现不可触及乳腺癌的能力。
AJR Am J Roentgenol. 1999 Feb;172(2):309-12. doi: 10.2214/ajr.172.2.9930773.
7
Management of probably benign breast lesions.
Radiol Clin North Am. 1995 Nov;33(6):1123-30.
8
Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up.筛查乳腺钼靶检查的乳腺癌检出率及短间隔随访建议
Radiology. 2005 Mar;234(3):684-92. doi: 10.1148/radiol.2343031976.
9
[Stereotaxic cytologic examination of non-palpable lesions of the breast. Experience with 791 consecutive cases].[乳腺不可触及病变的立体定向细胞学检查。791例连续病例的经验]
Radiol Med. 1991 Jan-Feb;81(1-2):65-8.
10
Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted?乳腺钼靶和超声检查发现的可触及的边界清晰的非钙化实性乳腺肿块的随访:能否避免活检?
Radiology. 2004 Dec;233(3):850-6. doi: 10.1148/radiol.2333031845. Epub 2004 Oct 14.

引用本文的文献

1
Two-stage augmentation for detecting malignancy of BI-RADS 3 lesions in early breast cancer.两阶段增强法用于检测早期乳腺癌中BI-RADS 3类病变的恶性情况。
BMC Cancer. 2025 Mar 24;25(1):537. doi: 10.1186/s12885-025-13960-0.
2
The Role of Predeployment Retraction in Biopsy Marker Migration During Stereotactic Breast Biopsies: A Randomized Controlled Trial.立体定向乳腺活检中预部署回缩在活检标记物移位中的作用:一项随机对照试验
J Breast Imaging. 2024 Nov 5;6(6):610-620. doi: 10.1093/jbi/wbae050.
3
Breast Cancer Detection with an Ensemble of Deep Learning Networks Using a Consensus-Adaptive Weighting Method.
使用共识自适应加权方法的深度学习网络集成进行乳腺癌检测
J Imaging. 2023 Nov 13;9(11):247. doi: 10.3390/jimaging9110247.
4
The dilemma of recalling well-circumscribed masses in a screening population: A narrative literature review and exploration of Dutch screening practice.在筛查人群中召回界限清楚的肿块的困境:文献综述叙述和对荷兰筛查实践的探索。
Breast. 2023 Jun;69:431-440. doi: 10.1016/j.breast.2023.05.001. Epub 2023 May 3.
5
A review of the current state of the computer-aided diagnosis (CAD) systems for breast cancer diagnosis.乳腺癌诊断的计算机辅助诊断(CAD)系统现状综述。
Open Life Sci. 2022 Dec 9;17(1):1600-1611. doi: 10.1515/biol-2022-0517. eCollection 2022.
6
BI-RADS 3 Assessment on MRI: A Lesion-Based Review for Breast Radiologists.MRI上的BI-RADS 3评估:针对乳腺放射科医生的基于病变的综述
J Breast Imaging. 2022 Jun 28;4(5):460-473. doi: 10.1093/jbi/wbac032. eCollection 2022 Sep-Oct.
7
Value of BI-RADS 3 Audits.乳腺影像报告和数据系统(BI-RADS)3类评估的价值
Biomed J Sci Tech Res. 2022 Feb;41(5):33086-33092. doi: 10.26717/BJSTR.2022.41.006668. Epub 2022 Feb 14.
8
BI-RADS 3 on Screening Breast Ultrasound: What Is It and What Is the Appropriate Management?乳腺超声筛查中BI-RADS 3类:是什么以及如何进行恰当管理?
J Breast Imaging. 2021 Aug 15;3(5):527-538. doi: 10.1093/jbi/wbab060. eCollection 2021 Sep-Oct.
9
Follow-Up Intervals for Breast Imaging Reporting and Data System Category 3 Lesions on Screening Ultrasound in Screening and Tertiary Referral Centers.乳腺影像报告和数据系统 3 类病变在筛查和三级转诊中心的筛查超声随访间隔。
Korean J Radiol. 2020 Sep;21(9):1027-1035. doi: 10.3348/kjr.2019.0747.
10
BI-RADS Category 3 Is a Safe and Effective Alternative to Biopsy or Surgical Excision.乳腺影像报告和数据系统(BI-RADS)3类是活检或手术切除的一种安全有效的替代方案。
Radiology. 2020 Jul;296(1):42-43. doi: 10.1148/radiol.2020201583. Epub 2020 May 19.